Mark Viduka will return to the Newcastle United side tomorrow night, when they return to the beautiful Emirates Stadium for tomorrowâ€™s Premier League game with Arsenal.
Mark Viduka – will definitely feature against Arsenal tomorrow
Emre is still suspended and will miss his 3rd game of a 3 game suspension after seeing a straight red card against Stoke City. Emre will be ready for Sunday’s game against Middlesbrough, and we think he’s looking forward to playing for the new attacking Newcastle side, under Kevin Keegan.
Shola Ameobi is still not 100% match fit and will probably not be involved again tomorrow night, although he needs games to be match fit.
Keegan told the Evening Chronicle today:
â€œMark Viduka will definitely be back for us at Arsenal tomorrow night.â€â€œAs he had been out for a week I told him to stay at home over the weekend and get himself a little bit sharper.â€
â€œI was always intending to play Mark on Tuesday because I want to have a look at different combinations and thatâ€™s not me rotating, itâ€™s me honestly looking and searching for little things we can build on.â€
Newcastle are down to the bare bones again, but Arsene Wenger may give a run out to some of his many youngsters available to him tomorrow night.
â€œWe sort of guessed Arsenal would play their strongest team against us on Saturday because of what happened to them at Spurs in midweek.â€
â€œThey could not really take a chance with us, but I would not be surprised if Arsene Wenger takes a chance on Tuesday night when he sees the video of Saturdayâ€™s game.â€
â€œHe will probably think he can cause us some problems with some of his fringe players he has got.â€
It could be that some of our 4 African players could be back later this week, as both Senegal and Nigeria have only a draw to show in their first two games. It will be good to get the boys back, after so much has changed at the club since they left.
But of course we’d like for them to do as well as they can, while they’re out there representing their countries.
Comments very welcome.